Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer PatientsAthina Markou, Evi Lianidou, Shukun Chen et al.|Clinical Chemistry|2017Cited by 76
Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate CancerWojciech A. Cieślikowski, Andrzej Antczak, Martine Mazel et al.|Cancers|2020Cited by 41
Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration AssaysJoanna Budna, Catherine Alix‐Panabières, Martine Mazel et al.|Cancers|2019Cited by 32
Liquid Biopsy Analysis as a Tool for TKI-Based Treatment in Non-Small Cell Lung CancerKarolina Buszka, Joanna Budna, Paula Kamińska et al.|Cells|2022Cited by 15
Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate CancerWojciech A. Cieślikowski, Joanna Budna, Agnieszka Ida et al.|Journal of Personalized Medicine|2023Cited by 13